Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 8, 2000, Pages 2793-2796

  Koshiyama, Hiroyuki ^a   Nakamura, Yoshio ^a   Tanaka, Satsuki ^a   Minamikawa, Jun ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; CAROTID ARTERY; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPENIA; PRIORITY JOURNAL;

BONE DISEASES, METABOLIC; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; ETIDRONIC ACID; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

ANIMALIA;

EID: 0034456560     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.8.2793     Document Type: Article

References (31)

1. Current therapy for osteoporosis
2. Comparison of changes in bone mineral density in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation
3. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women
4. The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis
5. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits
6. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids
7. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions
8. Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits
9. β-glycerophosphonate accelerates calcification in cultured bovine vascular smooth muscle cells
10. Intimal plus medial thickness of the arterial wall: A direct measrement with ultrasound imaging
11. Ultrasound B-mode imaging in observational studies of atherogehic progression
12. Common carotid arterial wall thickness in NIDDM subjects
13. Non-invasive assessment of cardiovascular disease in diabetes mellitus
14. Carotid arterial intimal-medial thickening and plaque formation in NIDDM
15. Effect of the combined therapy with vitamin D, vitamin K, etidronate in type 2 diabetes
16. Hormone and bones
17. Vitamin-D-receptor-gene polymorphism and bone loss
18. Therapeutic dilemma with thyroxine replacement in hypothyroidism
19. Is bone mineral density paradoxically increased in diabetic nephropahy?
20. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus
21. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
22. Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes
23. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
24. Decrease in intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency
25. Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits
26. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro
27. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
28. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study
29. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries
30. Carortid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects
31. Parathyroid hormone-related peptide as a local regulator of vascular calcification